Phenylalanine News and Research

RSS
Elevations in 5 amino acids may signal future disease risk

Elevations in 5 amino acids may signal future disease risk

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

BNCT treatment proves effective in treating recurrent head, neck cancer

BNCT treatment proves effective in treating recurrent head, neck cancer

Expansion of newborn screening throws some families on a journey of great uncertainty

Expansion of newborn screening throws some families on a journey of great uncertainty

Scientists determine tertiary structure of TehA membrane protein in Haemophilus bacteria

Scientists determine tertiary structure of TehA membrane protein in Haemophilus bacteria

BioMarin provides update on PEG-PAL Phase 2 clinical study for phenylketonuria

BioMarin provides update on PEG-PAL Phase 2 clinical study for phenylketonuria

New approach to protein misfolding may lead to novel therapies for a number of diseases

New approach to protein misfolding may lead to novel therapies for a number of diseases

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria

Patients with Phenylketonuria face increased risk of developing severe neurological complications

Patients with Phenylketonuria face increased risk of developing severe neurological complications

New tag could enable more detailed structural studies of mammalian proteins

New tag could enable more detailed structural studies of mammalian proteins

Marine derived compound may lead to new leukemia treatments

Marine derived compound may lead to new leukemia treatments

Research reveals new options for people with phenylketonuria

Research reveals new options for people with phenylketonuria

BioMarin receives notice of allowance for Kuvan patent

BioMarin receives notice of allowance for Kuvan patent

Novel stimulation method sparks hope for Parkinson's disease sufferers

Novel stimulation method sparks hope for Parkinson's disease sufferers

New drug shows promise for phenylketonuria

New drug shows promise for phenylketonuria

Merck Serono's Kuvan receives European marketing authorization

Merck Serono's Kuvan receives European marketing authorization

An improved gene therapy agent from University of Florida

An improved gene therapy agent from University of Florida

Drug therapy for phenylketonuria reverses heart damage

Drug therapy for phenylketonuria reverses heart damage

New method to determine the “selective signature” of a gene

New method to determine the “selective signature” of a gene

New phenylketonuria (PKU) treatment offered at Hayward Genetics Center

New phenylketonuria (PKU) treatment offered at Hayward Genetics Center